(NASDAQ: NEOG) Neogen's forecast annual revenue growth rate of 0.33% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.68%.
Neogen's revenue in 2025 is $905,996,000.On average, 3 Wall Street analysts forecast NEOG's revenue for 2025 to be $194,490,161,441, with the lowest NEOG revenue forecast at $193,207,465,283, and the highest NEOG revenue forecast at $196,925,330,797. On average, 3 Wall Street analysts forecast NEOG's revenue for 2026 to be $196,751,700,184, with the lowest NEOG revenue forecast at $192,860,204,056, and the highest NEOG revenue forecast at $203,861,873,810.
In 2027, NEOG is forecast to generate $202,506,686,871 in revenue, with the lowest revenue forecast at $195,160,809,686 and the highest revenue forecast at $212,771,294,671.